RecruitingNot ApplicableNCT07400042

Peripheral Venous Pressure (PVP) Trial

Reducing the Length of Stay and Incidence of Rehospitalization in Heart Failure Patients by Measuring Peripheral Venous Pressure; a Randomized Clinical Trial


Sponsor

Wake Forest University Health Sciences

Enrollment

600 participants

Start Date

Jul 27, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to determine if there is a reduction in the length of stay and rates of rehospitalization for patients diagnosed with congestive heart failure when physicians are provided daily measurements of peripheral venous pressure versus no daily measurements of peripheral venous pressure.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying peripheral venous pressure measurements and standard clinical care for people with congestive heart failure. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERperipheral venous pressure measurements

Peripheral venous pressure measures provided to physicians daily up to 8 days, with a research note in the electronic medical record containing standardized recommendations for case also provided daily. Care changes up to clinical provider discretion.

OTHERstandard clinical care

Usual standard clinical care


Locations(1)

Aurora St. Luke's Medical Center

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07400042


Related Trials